Publications by authors named "Navendu Samant"

Claim this Profile
E
Epidemiology and clinical characteristics of pediatric osteomyelitis in northern California.
Xiao Ben Wang, Navendu Samant, Justin Searns, Carol Glaser

World J Pediatr· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility study on elimination of all oral opioids following bariatric surgery.
Adam J Meyers, Pandu R Yenumula, Navendu D Samant, Gary Grinberg

Surg Obes Relat Dis· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesh Complication Rates Following Pelvic Radiation Therapy in Women With History of Synthetic Midurethral Sling Implantation.
Caitlyn E Painter, Julia Geynisman-Tan, Navendu Samant, Debbie Postlethwaite, Olga Ramm

Female Pelvic Med Reconstr Surg· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Breast cancer risk after hysterectomy with and without salpingo-oophorectomy for benign indications.
Stephanie Chow, Tina Raine-Bennett, Navendu D Samant, Debbie A Postlethwaite, Marie Holzapfel

Am J Obstet Gynecol· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
K
Knowledge, Attitudes, and Perceptions About Medicolegal Education: A Survey of OB/GYN Residents.
Shilpa Mathew, Navendu Samant, Christie Cooksey, Olga Ramm

Perm J· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical implications and economic impact of accuracy differences among commercially available blood glucose monitoring systems.
Erwin S Budiman, Navendu Samant, Ansgar Resch

J Diabetes Sci Technol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Economic burden of resected squamous cell carcinoma of the head and neck in a US managed-care population.
Mayur M Amonkar, Benjamin Chastek, Navendu Samant, April Teitelbaum

J Med Econ· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Treatment by NCQA-Certified Physicians on Diabetes-Related Outcomes.
Brett Pinsky, James Harnett, Ryne Paulose-Ram, Jack Mardekian, Navendu Samant

Am Health Drug Benefits· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Resource utilization with insulin pump therapy for type 2 diabetes mellitus.
Peter M Lynch, Aylin Altan Riedel, Navendu Samant, Ying Fan, Tim Peoples

Am J Manag Care· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved A1C by switching to continuous subcutaneous insulin infusion from injection insulin therapy in type 2 diabetes: A retrospective claims analysis.
Peter Lynch, Aylin Altan Riedel, Navendu Samant, Ying Fan, Tim Peoples

Prim Care Diabetes· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality of life as a potential predictor in chronic obstructive lung disease patients.
Fadia T Shaya, Navendu Samant, Francoise Pradel, C Daniel Mullins, Steven M Scharf

Expert Rev Pharmacoecon Outcomes Res· April 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Modeling risk of gastrointestinal events among Medicaid NSAID users using propensity scores.
Fadia T Shaya, Navendu Samant, Richard Skolasky, Elijah Saunders

Expert Rev Pharmacoecon Outcomes Res· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost studies in clinical trials.
Fadia T Shaya, Navendu Samant

Expert Rev Pharmacoecon Outcomes Res· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Formulary decision methodology in the context of health system costs and insurance trends.
Fadia T Shaya, Navendu Samant

Expert Rev Pharmacoecon Outcomes Res· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Formulary decision-making considerations: COX-2 inhibitors.
Fadia T Shaya, Winston Wong, James Y Shin, LeeAnn Martin, Navendu Samant

Manag Care Interface· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis